Introduction
Irritable bowel syndrome (IBS) is a chronic functional bowel disorder characterised by numerous episodic symptoms including abdominal pain, constipation, diarrhoea, and abdominal bloating. Prevalence estimates range from 7 to 20% in western populations (Andrews et al., 2005; Grundmann & Yoon, 2010) with reported female predominance in healthcare seeking (Andrews et al., 2005; Hungin, Chang, Locke, Dennis, & Barghout, 2005; Wilson, Roberts, Roalfe, Bridge, & Singh, 2004) . Many affected are frequent users of healthcare services (Talley, 2008) and may be referred for potentially costly secondary consultations (Wilson et al., 2004) . IBS contributes to lost working hours and productivity (Dean et al., 2005; Hungin et al., 2005; Wilson et al., 2004) and impacts negatively on multiple facets of quality of life including sleep, diet, sexual function, and travel (Amouretti et al., 2006; Dancey & Backhouse, 1993; Dancey, Hutton-Young, Moye, & Devins, 2002; Faresjö et al., 2006; Lea & Whorwell, 2001 ). Additionally, symptoms may result in significant emotional distress and those affected may "catastrophise" IBS symptoms as being indicative of a potentially life-threatening health condition (Lackner, Quigley, & Blanchard, 2004; Tanaka, Kanazawa, Fukudo & Drossman., 2011) . These issues highlight the need for effective treatment for IBS.
The aetiology of IBS is not fully understood and is currently linked to a complex interplay of biological and psychosocial factors (Tanaka et al., 2011) . Consequently conventional medical treatment for IBS is often pharmacologically orientated towards symptom relief rather than directed towards potential aetiological factors (Chey, Maneerattaporn, & Saad, 2011; Harris & Heitkemper, 2012) . Nevertheless, conventional medical treatment is frequently reported as unsatisfactory (Hayee & Forgacs, 2007) and considered limited given the scope of IBS symptoms. Many opt to use complementary and alternative medicine (CAM) in an effort to manage symptoms (Kong et al., 2005) .
Complementary and Alternative Medicine Use in IBS
CAM includes primarily self-funded treatments or therapies that operate on different philosophical principles from those of the biomedical model of conventional medicine (Zollman & Vickers, 1999 ). CAM's prevalence for IBS has been reported between 37 and 50% (Drossman et al., 2009; Kong et al., 2005; Langmead, Chitnis, & Rampton, 2002) with similar rates reported for inflammatory bowel disease (IBD) (Hilsden, Verhoef, Rasmussen, 4 Porcino, & DeBruyn, 2011; Langmead et al., 2002) . Demographically, CAM-users are more likely to be female, have a greater disposable income, higher educational attainment and chronic health conditions with prolonged symptom discomfort (Astin, 1998; Bishop & Lewith, 2010; Metcalfe, Williams, McChesney, Patten, & Jetté, 2010; Talley, Boyce, & Jones, 1997) .
The prevalence of CAM use presents a number of issues for those who practise conventional medical treatment of IBS. Firstly, CAM use may indicate that conventional medical care is not meeting patient treatment expectations, which may consist of either real or perceived shortcomings in medical care (Drossman et al., 2009; Smart, Mayberry, & Atkinson, 1986) .
Secondly, there is potential for harmful interactions between conventional pharmacologic treatment and some forms of CAM (Leung, Shalansky, Lo, & Jadusingh, 2009; ShaneMcWhorter & Geil, 2002; Vincent & Furnham, 1997) . Thirdly, many CAM treatments for IBS currently lack established efficacy (Ford et al., 2008) . In the UK, for example, National
Institute for Health and Clinical Excellence's guidelines for medical practitioners do not recommend the use of acupuncture or reflexology in IBS patients (NICE, 2008) . Clearly issues with both conventional medical and CAM treatments exist. One further option for management of symptoms is to incorporate psychological factors into treatment protocol.
The Role of Psychological Factors in IBS Management
The role of psychological factors in IBS has been emphasised by the lack of aetiological consensus and conjecture that disturbance in the pathways between brain and gut results in IBS symptoms (Quigley, 2006) . Evidence indicates that psychological factors related to illness, such as perceptions about illness, are important as they may impact on coping behaviours and quality of life (Hagger & Orbell, 2003; Rutter & Rutter, 2002) , illness experience and conventional healthcare seeking (Lea & Whorwell, 2004; van Dulmen, Fennis, Mokkink, van der Velden, & Bleijenberg, 1994 van Dulmen, Fennis, Mokkink, & Bleijenberg, 1996) .
Future healthcare seeking and anxiety have been shown to be reduced by following an intervention directed towards changing specific components of illness perceptions (Oerlemans, van Cranenburgh, Herremans, Spreeuwenberg, & van Dulmen, 2010; van Dulmen et al., 1996) . Information-based interventions have demonstrated benefits in symptom and anxiety reduction and improvements in quality of life through enhanced 5 feelings of control and understanding of IBS (Jarrett et al., 2009; Ringström et al., 2010; Robinson et al., 2006) . Illness related anxiety may also be reduced by giving a diagnosis of IBS (Hayee & Forgacs, 2007; Ilnyckyj, Graff, Blanchard, & Bernstein, 2003) . Addressing such components could potentially be incorporated into conventional medical consultations to aid effective management of IBS symptoms (e.g. van Dulmen et al., 1997) .
Psychological influences on CAM use
Beliefs and perceptions related to illness, treatment and healthcare have been implicated as factors important in CAM use. Concerns with efficacy of conventional medical treatment and dissatisfaction with doctor-patient communication have influenced CAM use in general (Bishop, Yardley, & Lewith, 2006; Horne, Weinman, & Hankins, 1999) and gastro-intestinal (GI) populations (Hilsden, Scott, & Verhoef, 1998; Scott, Verhoef, & Hilsden, 2003) .
General population studies have shown illness perceptions influence use of CAM (Bishop et al., 2006; Bishop, Yardley, & Lewith, 2007; Searle & Murphy, 2000) and CAM-users have been shown to report worse health status (Bishop & Lewith, 2010) , and in those affected by IBS, poorer quality of life (van Tilburg et al., 2008) than those not using CAM. CAM use may be further facilitated by a positive attitude towards CAM (Astin, 1998; Vincent & Furnham, 1996) . Similarly, when GI patients' perceived benefits of CAM use (i.e. decreased stress, anxiety and pain) outweigh perceived costs (i.e. financial outlay) CAM use is more likely (Giese, 2000) . These findings suggest CAM-users may report differing beliefs and perceptions compared to those not using CAM. Therefore, synthesis of existing findings regarding influences on CAM use in IBS may be used to inform the practitioner-client consultation and direct the development of psychological components of management strategies for this complex and often intractable condition.
Aim of the Review
The aims of the review were to quantify the extent of CAM use and explore psychological factors associated with CAM uptake in those affected by IBS.
Method Search Strategy
Electronic searches were conducted for articles published from 1978 onwards, when the Manning diagnostic criteria were published (Manning, Thompson, Heaton, & Morris, 1978) .
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Five electronic databases were searched to identify studies that examined the prevalence of and factors that influence CAM use in IBS. These included AMED, EMBASE, Cinahl, PubMed, and PsychINFO databases. The Cochrane database for systematic reviews was also searched. Searching was conducted using the terms "irritable bowel syndrome", "complementary" and "alternative". Further searches were carried out using the terms "functional gastrointestinal" and "functional bowel" in conjunction with the terms previously listed. Search terms are listed in Figure 1 .
Selection process and data analysis
One researcher (LU) conducted initial searches and selection of abstracts. Duplicates were removed from the search and all abstracts subsequently read. Where it was unclear if a study fitted the review criteria, the full text was obtained. There were two main inclusion criteria.
Firstly, studies had to include measurement regarding the extent of CAM use in IBS. 
Results
Five studies met the inclusion criteria. Studies were conducted in the UK (Smart et al., 1986 ), Holland (Donker, Foets, & Spreeuwenberg, 1999 , Canada (Verhoef, Sutherland, & Brkich, 1990) , Australia (Koloski, Talley, Huskic, & Boyce, 2003) and the US (van Tilburg et al., 2008) . Four studies used a survey/questionnaire design and one (Donker et al., 1999 ) used quantifiable structured interviews. A summary of findings is provided in Table 2 .
Included studies focused on participants with a functional bowel disorder (FBD, referring to IBS) or made sole reference to IBS. Recruitment and data collection varied from postal questionnaires (Smart et al., 1986) , to recruitment from a general practitioner clinic (Donker et al., 1999) and outpatient clinic (Smart et al., 1986; Verhoef et al., 1990) . Two studies used data collected from previous work by the respective authors, for example from a previous healthcare survey for those with FBD (van Tilburg et al., 2008) , and previous population surveys ( Koloski et al., 2003) . The studies reported female predominance in samples, ranging from 60 to75%.
Study Methodologies
All studies examined group differences. Two studies (van Tilburg et al., 2008; Verhoef et al., 1990 ) used one group of IBS/FBD outpatients and analysed participants in terms of those who had used or not used CAM. Smart et al. (1986) Koloski et al. (2003) compared an IBS group to healthy controls in addition to healthcare (including alternative healthcare) consulters and non-consulters. Smart et al. (1986) assessed the frequency of CAM use in patients with a diagnosis of IBS according to the Manning criteria (Manning et al., 1978) and for whom a clinical examination revealed no bowel abnormalities. Patients with organic GI disorders were recruited from the same outpatient clinic as those with IBS and Crohn's patients were contacted via post. All participants completed a questionnaire on alternative medicine consultations. Verhoef et al. (1990) however, examined patients who sought alternative treatment for the problem which had required a consultation with a GI specialist in the past two years. Differences in demographic profile and health status between CAM users and non-users were compared. Of the 395 GI patients recruited, 55 were classified as having a functional GI disorder with diagnosis made by four GI specialists. This study excluded patients who used CAM for health problems other than their diagnosed GI disorders. Participants completed a three item index based on scepticism towards conventional medicine and were asked about alternative medicine use during the previous two years. Donker et al. (1999) focused on the health status of 53 patients with IBS recruited from general practices participating in the Dutch National Survey of Morbidity and Intervention in General Practice and compared their use of healthcare services including CAM to a population sample of 10787. Participants were asked about healthcare use, health problems in the two weeks prior to being questioned and completed the General Health Questionnaire (GHQ) a screening tool for psychiatric illness (Goldberg, 1972) and the biographic problem list (BIOPRO) which measured social problems (Hosman, 1983) . Health related behaviour (e.g. smoking, exercise) and the amount of healthcare sought was also measured which ranged from seeing a doctor (previous three months), a physical therapist (previous 12 months), a specialist (last two years) and an alternative therapist (previous five years).
Using semi-structured interviews and questionnaires, Koloski et al. (2003) considered usage of both conventional and alternative healthcare in 207 patients with functional GI diagnoses (IBS or functional dyspepsia). Participants were recruited from one of two previous surveys carried out by the authors and separated into consulters or non-consulters for both conventional and alternative healthcare. Participants were asked about frequency, access and satisfaction with healthcare. The structured interview for bowel symptoms was administered to give a functional diagnosis based on the Rome I criteria (Drossman et al., 1994) . This structured interview also accounted for aspects related to quality of life and extent of symptoms. In addition, participants were given the Composite International Diagnostic Interview (World Health Organisation, 1997) designed to assess past and current psychological disturbance.
Using data from 1012 FBD patients recruited from an "outpatient" healthcare maintenance organisation in a previous study (Nyrop et al., 2007) , van Tilburg et al. (2008) examined CAM use in IBS and FBD. Participants were assessed for symptom severity at a "baseline" visit to the clinic with the Irritable Bowel Syndrome Severity Scale (IBS-SS) (Francis, Life scale, IBS-QOL (Patrick et al., 1998) , psychological distress using the Brief Symptom inventory (BSI) (Derogatis, 1993) , perceived treatment effectiveness, and CAM use.
Extent of CAM Use
The reviewed studies indicated CAM use at between 9 and 38.4%. Smart et al. (1986) found significantly more of those with IBS had visited an alternative practitioner compared to Crohn's and organic GI patients. Current alternative medicine use was significantly greater in the IBS group and herbal treatments and homeopathy were used most frequently (Smart et al., 1986) . Verhoef et al. (1990) reported that 50% of CAM-users had FBD (compared to 13% of non-CAM users) and 9% used CAM for the condition they presented to a gastroenterologist.
Chiropractors (for conditions other than GI), herbalists, naturopaths and reflexologists were that most frequently CAM practitioners and 46% of participants had visited more than one type of CAM practitioner. Donker et al. (1999) found the IBS patient group had paid significantly more visits to an alternative practitioner than the population group (32% compared with 15%). Koloksi et al. Smart et al. (1986) or Verhoef et al. (1990) specifically examined the role of gender although Donker et al. (1999) reported that a majority of IBS patients were female.
Reasons for CAM Use
Van Tilburg et al. (2008) found being female and higher educational attainment predicted CAM use. Verhoef et al. (1990) reported that a functional diagnosis was an independent predictor of CAM use compared to those with organic GI disorders. Similarly, Smart et al. (1986) reported more patients with IBS than Crohn's used CAM. Donker et al. (1999) found significantly more IBS outpatients used CAM than the population group and those with IBS reported significantly more intense symptoms (e.g. abdominal pain
Perception of Symptoms
and "secondary" symptoms including tiredness, backache and headaches). Koloski et al. (2003) found that physical symptoms of IBS significantly predicted conventional care seeking rather than CAM use. Van Tilburg et al. (2008) found stronger perceptions of symptom severity were associated with CAM use but not when controlling for demographics and other variables (e.g. the IBS-QOL and IBS-SS) in a logistic regression model. Smart et al. (1986) found that the IBS group were more likely to report using alternative treatments if they perceived conventional treatment had failed. Verhoef et al. (1990) observed that 54% of CAM-users with GI disorders (including IBS) were satisfied with conventional treatment compared with 85% of non-CAM participants and that GI patients who used CAM were significantly more sceptical (49%) of conventional medicine than those not using CAM (13%). Verhoef et al. (1990) also revealed associations between a functional diagnosis and scepticism towards conventional medicine, and that these variables both (independently)
Patient Perception of Conventional Treatment
significantly predicted the use of CAM. In relation to communication between conventional practitioner and patient, CAM-users were less satisfied with responses from conventional practitioners than non-CAM users (77% vs 91%). Koloski et al. (2003) found dissatisfaction did not significantly influence CAM use, although there was some difference between CAMusers and non-CAM users. Van Tilburg et al. (2008) found no association between CAM use and satisfaction with physician care during their primary visit and that CAM-users did not rate their conventional prescription medication as being less effective than non-CAM users.
Beliefs about CAM Treatments and Therapies
One study reported expectations of CAM efficacy as a rationale for IBS patients to use CAM. Koloski et al. (2003) found a desire to treat the GI problem with a more natural approach, the potential for alternative treatments to work and personal recommendation were all factors (albeit not significant) that appear to influence CAM use. Donker et al. (1999) reported that 92% of CAM-users felt CAM had helped.
Other Psychosocial Factors Verhoef et al. (1990) found stressful life events in the previous year significantly predicted CAM use in those with FBD. Donker et al. (1999) reported that those with IBS had higher scores on the GHQ than the population group. Differences were observed in the two groups'
BIOPRO scores where those with IBS reported greater concerns about the future, lower selfconfidence, fewer social interactions, and relationship difficulties. The IBS group reported more occupational absence in the two months prior to the study. Additionally, having IBS resulted in significantly more visits to the family GP, a physical therapist and a GI specialist.
The significant differences observed in healthcare seeking (including CAM use) between the two groups may be influenced by such psychosocial factors (Donker et al., 1999) . Koloski et al. (2003) observed differences, albeit not significant, between both sets of healthcare consulters (CAM and conventional treatment) and non-consulters in psychological disturbance and perception of symptoms. Van Tilburg et al. (2008) found CAM-users reported significantly poorer IBS-QOL scores compared to those not using CAM. CAM-users also reported higher scores on the somatisation, anxiety and depression subscales of the BSI.Logistic regression analysis revealed that anxiety was the sole significant psychosocial predictor of CAM use.
Discussion
Prevalence of CAM was lower than CAM use reported by Kong et al. (2005) and Langmead et al. (2002) . However, this might be explained by reviewed studies focusing on consultation with a CAM practitioner as opposed to self-directed treatments (Kong et al., 2005) . The reviewed studies included patient group and healthy control population comparisons, in 16 addition to comparisons of those with IBS who used CAM and those not using CAM.
Findings indicate that those with IBS who use CAM may report more severe symptoms and have concerns about conventional medicine including unhappiness and dissatisfaction with conventional care.
Female predominance was evident, which is concurrent with what is known about IBS (e.g. Andrews et al., 2005) , however, in terms of CAM, there was limited agreement with findings from non-illness specific investigation into CAM use. CAM use in general has been reported to have female predominance (e.g. Astin, 1998) , although only one reviewed study (van Tilburg et al., 2008) found that being female was an independent predictor of CAM use in those with a functional GI diagnosis. It should be noted however that the reviewed studies had a predominantly female representation which is consistent with previous findings that a greater proportion of females than males seek healthcare for IBS/functional GI symptoms (Andrews et al., 2005; Hungin et al., 2005) . It has yet to be ascertained whether this disparity between males and females is due to biological or environmental distinctions related to gender or might be explained by differences in healthcare seeking (Corazziari, 2004) .
Although there has been limited examination of many psychological aspects in general populations of CAM-users, points of contrast and similarity exist with what is currently known about possible psychological influences on CAM use. Illness related perceptions, for example, were not found to be strong influences on CAM use. This is in contrast to findings from Bishop et al. (2006) who found stronger perceived consequences of illness (from a general population) predicted use of CAM. This finding may be more indicative of a lack of measurement of such constructs. With illness perceptions being a key component for intervention in IBS (e.g. Oerlemans et al., 2010) this represents one important aspect that could be addressed by future research. CAM-users however, reported poorer quality of life and more severe symptoms, which concurs to an extent with Astin (1998) who established CAM-users from a general population reported poorer health than those not using CAM.
There are further similarities in CAM-users affected by IBD who report amplified symptom perception and poorer quality of life (Hilsden et al., 1998; Langmead et al., 2002; Scott et al., 2003) . One study (Koloski et al., 2003) found increased perception of IBS symptoms predicted conventional care seeking suggesting it worthwhile to investigate this further in relation to use of CAM.
Treatment related beliefs however, appeared more influential on CAM use than illness perceptions. For example, findings showed a negative perception of conventional medical care influenced CAM use as did a desire to treat GI symptoms with a more natural approach (Bishop et al., 2006; Vincent & Furnham, 1996) . A degree of dissatisfaction with conventional medicine also appears evident, as found by Scott et al. (2003) in IBD patients.
However, future research should clarify whether this is due to issues with conventional treatment itself and the healthcare consultation, or both factors.
A major strength of this review is that it is the first to synthesise both prevalence estimates Conversely this review has a number of limitations that need to be considered. Due to differences in sample size and measures used in the selected studies, meta-analysis was not deemed appropriate due to variation in both study design and reporting of findings.
However, across the five reviewed studies, there were common themes why those with IBS turn to CAM although the methodological variation in the studies makes generalisation of findings problematic and potentially limited. Group comparisons in each study differed notably and it might be suggested that a protocol of studying CAM-users compared with those not using CAM may be advantageous in terms of explaining psychological influences on CAM use more precisely. There may also be benefit in examining factors that pull people to different forms of CAM (Bishop et al., 2006) as findings suggested that CAM is, at least partially, sometimes viewed as a single entity in terms of treatment. The reviewed studies were also conducted in different countries where differences in healthcare service provision may exist in addition to cultural differences. Furthermore, there was variation in participant 18 numbers in each of the studies. Two studies for example (Donker et al., 1999; Verhoef et al., 1990 ) had relatively small numbers of participants with IBS/FBD. There is some ambiguity concerning the scope of functional GI diagnosis (Verhoef et al., 1990) and if all participants had IBS or different functional diagnoses (such as functional dyspepsia) (Koloski et al., 2003) .
It was notable that none of the reviewed studies considered emotional response to illness, something that is often a concern in those with IBS (e.g. Tanaka et al., 2011) . CAM use was however predicted by higher reported anxiety in one study (van Tilburg et al., 2008) Furthermore in relation to concerns about conventional medical treatment, "failure" of (Smart et al., 1986) and "dissatisfaction" with conventional treatment (Koloski et al., 2003) may reflect sub-dimensions of the same construct. Both refer to treatment, the consultation or both. In the studies reviewed, measurement of these factors varied considerably. Koloski et al. (2003) conducted a healthcare seeking interview while Smart et al. (1986) asked specifically about failure of conventional treatment. Verhoef et al. (1990) assessed scepticism towards conventional medicine. Van Tilburg et al. (2008) considered first healthcare visits and perceived effectiveness of prescription medication. Moreover, four studies (Donker et al., 1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et al., 1990) focused solely on CAM consultations thus neglecting "off the shelf" products from the analysis. Clarification of the nature of dissatisfaction and a more expansive inclusion of CAM, which would include selfpurchased treatments and consideration of different forms of CAM, are additional factors that could be addressed in future research.
Conclusion and implications
CAM's use has been shown to be associated with psychological factors which could be targeted through psychologically based management strategies for those affected with IBS.
Such interventions may be beneficial in addressing negative symptom or treatment perceptions and emotional distress that may accompany IBS symptoms (e.g. van Dulmen et al., 1996) in addition to focusing on providing information about IBS (e.g. Jarrett et al., 2009) . It is possible that CAM-users may initially benefit more from such intervention as evidence suggests those with IBS using CAM report an amplified or more intense illness experience than those not using CAM. This may extend to CAM-users reporting poorer quality of life despite using CAM although future longitudinal studies are required to support this. The array of psychological factors identified by this review also suggests that the application of a theoretical framework to future research may aid understanding and inform translation to practical interventions. One such model, the common-sense model of illness representation (Leventhal, Brissette, & Leventhal, 2003) has incorporated both illness perceptions and treatment beliefs (e.g. Bishop et al., 2006) . This model has had success in both exploration and translation of findings into practical change in illness perceptions resulting in benefits to health (McAndrew et al., 2008) .
